The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research
Friday, August 22, 2014
World's Largest Pharmaceutical Company Signs Agreement with ViaCyte for a Stem Cell Treatment for Type 1 Diabetes
It's been a very good week for San Diego based regenerative medicine company ViaCyte and a potentially pivotal week for people battling type 1 diabetes.
No comments:
Post a Comment